Nutrition in critically ill patients with diabetes
DOI:
https://doi.org/10.47196/diab.v59i2Sup.1244Keywords:
hyperglycemia, diabetes, hospitalized patientsAbstract
Physiologically, any injury that triggers a "critical illness" response is associated with insulin resistance as a result of sympathetic activation, the release of stress hormones, and inflammatory mediators. When patients with diabetes mellitus (DM) are critically ill and admitted to intensive care, glycemic management may be different from that of non-diabetic patients. There are many studies seeking to estimate the best strategy for glycemic control in critically ill patients. Two main strategies have been studied: liberal control with a control target when blood glucose levels are greater than 180 mg/dL, and a stricter one. Liberal control appears to be the most appropriate as it reduces the risk of hypoglycemia, while strict control has not shown any benefits, except in one widely criticized study. It should be noted that these studies do not discriminate between diabetic and non-diabetic patients.
There are many studies seeking to estimate the best strategy for glycemic control in critically ill patients. Two main strategies have been studied: liberal control with a control target when blood glucose levels are greater than 180 mg/dL, and a stricter one. Liberal control appears to be the most appropriate as it reduces the risk of hypoglycemia, while strict control has not shown any benefits, except in one widely criticized study. It should be noted that these studies do not discriminate between diabetic and non-diabetic patients.
Regarding enteral formulas, most DM-specific formulas contain a mixture of complex carbohydrates, such as fructose, corn starch, or fiber, which slow gastric emptying and reduce intestinal transit, thus facilitating better glycemic control. Studies in healthy adults investigating the impact of whey protein have shown an increase in insulin and incretin secretion, which slows gastric emptying and improves glycemic control. However, these effects of slow gastric emptying on glycemic control have not been confirmed in critically ill patients.
In recent years, several studies have investigated the effect of nutritional formulas on glycemic control. Eckert et al. conducted a systematic review and meta-analysis investigating the association between specialized enteral nutrition formulas and glycemic control, as well as clinical outcomes. They found that specialized enteral nutrition formulas facilitated a reduction in insulin use and improved glycemic control. No significant associations with clinical outcomes were found; however, this is likely due to variations in study designs and target groups.
References
I. Amiel SA, Aschner P, Childs B, Cryer PE, de Galan BE, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. The Lancet Diabetes and Endocrinology 2019;7(5):385-396. doi: 10.1016/S2213-8587(18)30315-2.
II. Bohé J, Abidi H, Brunot V, Klich A, Klouche K, et al. Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study. A randomized clinical trial. Intensive Care Medicine 2021;47(11):1271-1283. doi: 10.1007/s00134-021-06526-8
III. Carvalho G, Lattermann R, Codere-Maruyama T, Schricker T. Glucose and insulin administration while maintaining normoglycemia: The GIN concept. Minerva Anestesiologica 2013;79(1):74-82.
IV. Doola R, Preiser JC. Nutritional therapy in critically ill patients with diabetes. Current Opinion in Clinical Nutrition and Metabolic Care 2022;25(2):93-98. doi: 10.1097/MCO.0000000000000807.
V. Eckert I, Kumbier MCC, Silva FM, de Almeida JC. Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients. A meta-analysis of randomized controlled trials. Clinical Nutrition 2021;40(6):3940-3949. doi: 10.1016/j.clnu.2021.04.030.
VI. Thouy F, Bohé J, Souweine B, Abidi H, Quenot JP, et al. Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial. Critical Care 2022;26(1). doi: 10.1186/s13054-022-04004-1.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.






















